Principal Investigator
Jaime Merchan
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240538
Clinical Trial Summary
A Phase 1/1b Study of VET3-TGI Administered Alone and in Combination with Atezolizumab in Patients with Advanced Solid Tumors
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
305-243-2647